enfuvirtide

(redirected from Fuzeon)
Also found in: Medical.
Related to Fuzeon: Rescriptor, Selzentry

en·fu·vir·tide

 (ĕn-fyo͞o′vîr-tīd′)
n.
An antiretroviral drug of the fusion inhibitor class used in combination with other drugs to treat HIV infection.

[en(try/)fu(sion inhibitor) + -vir, antiviral suff. (ultimately from virus) + (pep)tide.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

enfuvirtide

n enfuvirtida
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
The two FDA-approved entry inhibitors are enfuviritide (Fuzeon) and maraviroc (Selzentry).
Due to disadvantages of enfuvirtide (fuzeon), scientists have tried to discover small molecules which inhibit fusion process.
The assessment affects nineteen centrally authorised medicines as well as various medicines that have been nationally authorised: Avastin, Bondenza, Bondronat, Bonviva, Cellcept, Fuzeon, Herceptin, Invirase, Mabthera, Mircera, Neorecormon, Pegasys, Roactemra, Tamiflu, Tarceva, Viracept, Xeloda, Xenical and Zelboraf.
The company said the overall decline in net income for the quarter 2011 resulted primarily from decreased worldwide net sales of FUZEON and increased general and administrative fees related to the Trimeris process, to evaluate and identify a strategic partner and its proposed merger with Synageva BioPharma Corp.
The Triad Group alcohol prep pads are co-packaged and distributed with Genentech medicines Boniva Injection, Fuzeon, Nutropin AQ Pen, Pegasys, and TNKase to customers in the USA.
Because the HIV drug Fuzeon was developed in North Carolina, Hoffmann- LaRoche argued in In Re Hoffmann LaRoche Inc.
One drug that works like this is Fuzeon (Roche), and there are other agents in the pipeline.
Everyone who entered the trial had a viral load above 1000 copies when the study began, and no one had taken Kaletra, Prezista, Aptivus (tipranavir), or Fuzeon (enfuvirtide) before.
These drugs comprise a diverse class of proteins, including antibodies and derivatives (e.g., Humira, Herceptin, Enbrel), interferons (e.g., Pegasys, Betaseron, Avonex) and peptides (e.g., Forteo and Fuzeon).
One of them is enfuvirted, sold under the brand-name Fuzeon. Fuzeon is the first of a new class of AIDS drugs working through a novel mechanism.
One of them is enfuvirtid, sold under the brandname Fuzeon. Fuzeon is the first of a new class of AIDS drugs, working through a novel mechanism.
It will continue to sell its HIV treatment, Fuzeon. The company earned $9.1 million, or 41 cents per share, compared with a profit of $4.7 million, or 21 cents per share, during the same period a year ago.